Revenio Group Corporation Stock Exchange Release February 27, 2014 at 13:05
REVENIO GROUP CORPORATION PUBLISHES ANNUAL REPORT 2013
Today, Revenio Group Corporation published the annual report for 2013. The AR, available in Finnish in PDF format on the corporations website at www.revenio.fi, contains financial statements for the corporation and parent company, the report of the Board of Directors, auditors report and a report on corporate governance. English version of the AR will be available later.
The AR will be published in print in week 12. To order a copy, place an order with Revenio Group Corporation, Äyritie 22, FI-01510 Vantaa, tel. +358 50 382 0131 or by e-mail elina.kari@revenio.fi.
Revenio Group Corporation
Olli-Pekka Salovaara
President and CEO
For further information, please contact:
Olli-Pekka Salovaara, President and CEO, mobile +358 40 567 5520
olli-pekka.salovaara@revenio.fi
http://www.revenio.fi
DISTRIBUTION:
NASDAQ OMX Helsinki
Financial Supervisory Authority (FIN-FSA)
Key media
www.revenio.fi
The Revenio Group in brief
Revenio is a Finnish health tech group whose core business is tonometers. The Revenio Health Tech segment comprises the business operations of Icare Finland Oy. The widely patented Icare product family is the current cornerstone of the Group's success. Revenio seeks vigorous growth in health technology, both organically and through acquisitions and mergers. The Revenio Group also includes other business operations, which are grouped under the Technology and Services segment. This segment's operations have a shared global market and represent the cutting edge of technology products and services in their industry. These businesses are extremely profitable in their industries and generate positive cash flow.
In 2013, the Revenio Group's net sales totaled EUR 25.7 million, with its operating margin standing at 21.7%. The Revenio Group Corporation is listed on NASDAQ OMX Helsinki.
